From: Health burden and economic impact of measles-related hospitalizations in Italy in 2002–2003
Age group in years | ||||||||
---|---|---|---|---|---|---|---|---|
<1 | 1–4 | 5–9 | 10–14 | 15–19 | ≥ 20 | Total | p-value | |
N. Hospitalizations | 343 | 1216 | 1160 | 759 | 571 | 1105 | 5154 | |
Non-complicated measles (%) | 150 (43.7) | 506 (41.6) | 486 (41.9) | 375 (49.4) | 315 (55.2) | 558 (50.5) | 2390 (46.4) | <0.001 |
Pneumonia (%) | 48 (14.0) | 198 (16.3) | 176 (15.2) | 60 (7.9) | 34 (5.9) | 78 (7.0) | 594 (11.5) | <0.001 |
Other respiratory tract complications (%) | 49 (14.3) | 144 (11.8) | 135 (11.6) | 79 (10.4) | 56 (9.8) | 88 (8.0) | 551 (10.7) | <0.001 |
Enteritis/diarrhea/volume depletion (%) | 23 (6.7) | 125 (10.3) | 115 (9.9) | 59 (7.7) | 34 (5.9) | 156 (14.1) | 512 (9.9) | 0.006 |
Encephalitis (%) | 4 (1.2) | 18 (1.5) | 37 (3.2) | 30 (3.9) | 17 (3.0) | 32 (2.9) | 138 (2.7) | 0.016 |
Convulsions (%) | 7 (2.0) | 70 (5.7) | 16 (1.4) | 7 (0.9) | 1 (0.2) | 0 (0.0) | 101 (2.0) | <0.001 |
Otitis media (%) | 10 (2.9) | 36 (3.0) | 25 (2.2) | 12 (1.6) | 6 (1.0) | 12 (1.1) | 101 (2.0) | <0.001 |
Conjunctivitis/keratoconjunctivitis (%) | 4 (1.2) | 15 (1.2) | 21 (1.8) | 14 (1.8) | 16 (2.8) | 38 (3.4) | 108 (2.1) | <0.001 |
Thrombocytopenia (%) | 2 (0.6) | 3 (0.2) | 3 (0.2) | 7 (0.9) | 5 (0.9) | 6 (0.5) | 26 (0.5) | 0.170 |
Abortion/threatened abortion/antepartum or fetal complication (%) | 1 (0.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.3) | 17 (1.5) | 20 (0.4) | <0.001 |
Other infections/septicemia (%) | 16 (4.7) | 48 (3.9) | 47 (4.0) | 25 (3.3) | 17 (3.0) | 57 (5.1) | 210 (4.1) | 0.514 |
Other measles complications (%) | 54 (15.7) | 142 (11.7) | 161 (13.9) | 112 (14.7) | 117 (20.5) | 259 (23.4) | 846 (16.4) | <0.001 |
Other diagnoses (%) | 50 (14.8) | 170 (14.0) | 170 (14.6) | 121 (15.8) | 75 (13.1) | 314 (28.4) | 899 (17.5) | <0.001 |
Total N. Diagnoses | 418 | 1475 | 1392 | 901 | 695 | 1615 | 6496 |